𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mechanism of lidocaine release from carbomer–lidocaine hydrogels

✍ Scribed by Alvaro Jimenez-Kairuz; Daniel Allemandi; Ruben H. Manzo


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
138 KB
Volume
91
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


Rheology, acid-base behavior, and kinetics of lidocaine release of carbomer±lidocaine (CÀL) hydrogels are reported. A series of (CÀL) x (x mol% of L 25, 50, 75, 100) that covers a pH range between 5.33 and 7.96 was used. Concentrations of ion pair ([R-COO À LH ]) and free species (L) and (LH ) were determined by the selective extraction of (L) with cyclohexane (CH) together with pH measurements, i.e., CH in a ratio CH/hydrogel 2:1 extracted 48% of the whole concentration of lidocaine

The remaining species in the aqueous phase were distributed as: (L) 3.82%, (LH ) 14.5%, and [R-COO À LH ] 81.7%. Rheology and pH as a function of (CÀL) concentration are also reported. Delivery rates of free base L were measured in a Franz-type bicompartmental device using water and NaCl 0.9% solution as receptor media. (CÀL) hydrogels behave as a reservoir that releases the drug at a slow rate. pH effects on rate suggest that, under the main conditions assayed, dissociation of [R-COO À LH ] is the slow step that controls releasing rates. Accordingly, release rate was increased upon addition of a second counterion (i.e., Na ), or through the diffusion of neutral salts such as NaCl, into the matrix of the gel.


📜 SIMILAR VOLUMES


Lidocaine release from polycaprolactone
✍ Giuseppe Perale; Tommaso Casalini; Valentina Barri; Michele Müller; Simone Macca 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB
Macromolecule release from monodisperse
✍ Berkland, Cory (author);Pollauf, Emily (author);Raman, Chandrashekar (author);Si 📂 Article 📅 2007 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 430 KB

Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule delivery requires invasive methods such as frequently repeated injections. Parenteral depots including biodegradable polymer mic